Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) announced that findings from its study on gold nanorods for tumor hyperthermia will be presented at the 19th Canadian Melanoma Conference on February 20 in Vancouver.
Sona’s Chief Medical Officer, Dr Carman Giacomantonio, and Dr Barry Kennedy of The Giacomantonio Immuno-Oncology Research Group will deliver both poster and oral presentations.
The conference, hosted by OncologyEducation, is Canada’s leading melanoma research event, gathering experts to discuss advancements in treatment and emerging therapies.